Manuscripts are received with the understanding that they contain original data that are not previously published or are being considered for publication elsewhere. Authors are required to submit the manuscript along with all concerned certificates and documents copyright form, submission form, corresponding author form, contribution form available on the web site of the journal. In case of any queries or additional information, you can write an e-mail to the Editor-in-Chief of the journal at 9vom365@gmail.com.

The manuscript must have separate documents for:

  • Cover letter,
  • Research Article/Case Review/Original Research/Review Article file,
  • Figure/Table/Graph/Flowchart (with descriptive legends) doc.

 

All authors interested in publishing their research work in Hypertension Journal will need to submit their manuscripts for publication through a web-based manuscript tracking system. The authors can submit new manuscript, revise their existing manuscripts, upload other required documents. They can as well track the status of their manuscripts, which are already submitted. This system helps the editorial office to communicate with the associate editors, reviewers and thus manage the peer review process. The same system is used for communication with authors. Please go to our website and register yourself (if first time user) to submit the manuscripts.

Manuscripts are received with the understanding that they contain original data that are not previously published or are being considered for publication elsewhere. Authors are required to submit the manuscript along with all concerned certificates and document. In case of any queries or additional information, you can write an e-mail to the Editor-in-Chief of the journal.

Manuscript Fees

Authors should note that there are no processing charges for publication of an article in the journal.

Plagiarism/Copyright/Licensing

Please refer to the policies and conduct section on the website for more details.

Types of Submissions Accepted

All types of submissions / papers should follow a standard format as described below.

Editorials:

Usually provide commentary and analysis concerning an article in the issue of the Journal in which they appear. The editorials would be limited to 1000 words with up to 10 references.

Original Articles:

Reports of original clinical and basic research of interest to the medical community are the primary material to be published as original articles. Randomly controlled trials intervention studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analysis, case-control series, and surveys with a reasonably high response rate. The text would be limited to 3000-3500 words, with an abstract of 250 words, maximum of 5 tables and figures (total) and up to 40 references.

Reviews and Clinical Debates:

An article review is both a summary and an evaluation of another writer's article. They would cover a contemporary topic and would generally be wide-ranging overviews of a field of research. The reviews and clinical debates will be subject to the standard review process. The minimum word length would be 3000 and maximum would be 3500 words with 50 references.

Case Reports/Study:

The Journal encourages the submission of case reports that highlight practical diagnostic and/or management considerations. The format of these papers should follow that described in the “Manuscript Components” section above.

 

Case Series:

Case-series is a descriptive study design and as the name suggests, it is just a series of cases of any particular disease or disease discrepancy that one might observe in one's clinical practice etc.

Letters to the Editor:

The Journal accepts Letters to the Editor that raises some issues related to recently published articles (last 2 issues) in the Journal. The letters should not exceed (1000 words) of text and 5 references. While not all “Letters to the Editor” will be published, those that are judged worthwhile will be forwarded to the authors of the articles in question or to selected experts in order to provide the opportunity for a response. Whenever possible, they will be published with the reply of the author of the published article.

Processing of Accepted Manuscripts

Manuscripts are accepted with the understanding that the Editor and the editorial staff have the right to make revisions aimed at greater conciseness, clarity, and conformity with Journal style. Preliminary page proofs will be sent to the corresponding author. Authors who will be away from their offices for a long period or who change address after notification of acceptance should inform the Journal staff.

 

Preparing Manuscript

 

Manuscript Preparation

The manuscript must have separate documents for:

  • Cover letter,
  • Research Article/Case Review/Original Research/Review Article file (without author/ institution) along with Figure/Table/Graph/Flowchart (with descriptive legends) doc.

Manuscript Components

Microsoft Word 97-2013 or higher document file must be used to submit a manuscript. The text must be double spaced with 1” margins and justified to the left-hand margin. Avoid using “styles” or document templates. The “Normal” Word format is recommended. (Times New Roman-12 point text is expected) Please number all pages.

Title

The title of the manuscript should appear at the top of the first page. The title must clearly state what the article is about.

Cover Letter

A cover letter is a letter addressed to the Editor-in-Chief of the journal stating why the journal should consider your article for publication.

Title Page

It includes Article title, keywords, abstract and article text.

Corresponding Address: Submitted on web during submission. No author details must be mentioned on the article file.

Short title: A short title that is running head of no more than 45 characters, including spaces to be provided.

Author Names

Do not include author names in the manuscript in order to preserve anonymity during the review process. Authors' names need to be included during submission metadata while submitting the file on the journal's web site.

Abstract

All articles must include a structured abstract of approximately 200 to 250 words and only include material appearing in the main body of the manuscript. Authors are required to indicate the relevance in a statement of clinical significance within the abstract of the manuscript as well as at the end of the main body of the text.

Structured abstracts vary according to the type of article. All abstracts must be organized into a structured format appropriate to the type of article using the headings listed in the following table:

 Primary Research

Literature Reviews

Case Reports

Clinical Techniques

Aim

Aim

Aim

Aim

Materials & Methods

Background

Background

Background

Results

Review Results

Case Description

Technique

Conclusion

Conclusion

Conclusion

Conclusion

Clinical Significance

Clinical Significance

Clinical Significance

Clinical Significance

 

 Keywords

A list of minimum 3 to upto 5 keywords contained in the article must be listed below the abstract. They should contain the type of research such as systematic review, randomized clinical trial, cohort study, case-control study, laboratory research, or "other". (These will be used to search for your article on PubMed and other Internet resources.)

 

BODY OF THE MANUSCRIPT

The body of the manuscript must be organized into a format appropriate for the type of article using bold headings as listed in the following table:

Primary Research

Literature Reviews

Case Reports

Clinical Techniques

Introduction

Background

Background

Background

Materials & Methods

Review Results

Case Description

Technique

Results

Discussion

Discussion

Discussion

Discussion

Conclusion

Conclusion

Conclusion

Conclusions

Clinical Significance

Clinical Significance

Clinical Significance

Clinical Significance

Acknowledgment

Acknowledgment

Acknowledgment

References

References

References

References

 

Abbreviations: Spell out all abbreviations (other than those for units of measure) the first time they are used; idiosyncratic abbreviations should never be used.

Drugs Name: Generic rather than trade names of drugs should be used.

Nomenclature

 Use correct and established nomenclature wherever possible.

Units of measurement

Please use SI units. If not used exclusively, provide the SI value in parentheses after each value.

Drugs

Please provide the Recommended International Non-Proprietary Name (rINN).

Species names

Mention in italics (e.g., Homo sapiens). Also write out in full the genus and species, both in the title of the manuscript and at the first mention of an organism in a paper. After first mention, the first letter of the genus name followed by the full species name may be used (e.g., H. sapiens).

Genes, mutations, genotypes, and alleles

Write in italics. Use the recommended name by consulting the appropriate genetic nomenclature database (e.g., HGNC for human genes; we strongly recommend using this tool to check against previously approved names). It is sometimes advisable to indicate the synonyms for the gene the first time it appears in the text. Gene prefixes such as those used for oncogenes or cellular localization should be shown in roman typeface (e.g., v-fes, c-MYC).

Allergens

The systematic allergen nomenclature of the World Health Organization/International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-committee should be used for manuscripts that include the description or use of allergenic proteins. For manuscripts describing new allergens, the systematic name of the allergen should be approved by the WHO/IUIS Allergen Nomenclature Sub-committee prior to manuscript publication. Examples of the systematic allergen nomenclature can be found at the WHO/IUIS Allergen Nomenclature site.

 

 

References/Tables/Figures

 

References:

The Journal uses “Vancouver” style, as outlined in the ICMJE sample references.

Some essential pointers:

  • References are numbered in the text, either in line with the text within brackets (1) or using superscript¹, in the increasing order in which they appear.
  • A reference which is cited more than once is given the same number.
  • The references are then listed at the end of the text in numerical order by their order of appearance in text. Do not arrange the list alphabetically.
  • Accuracy of the citation is the author’s responsibility.
  • Authors should ensure that all references listed have been cited in text.
  • Personal communications and similar unpublished items should not appear in the reference list. Such citations may be noted in text.
  • DOI of the references should be included wherever available.

 

Tables:


The Journal does not publish tables that have been submitted elsewhere or previously published. Tables that duplicate material contained elsewhere in the manuscript (in text, figures, or other tables) will not be used. Authors should delete tables containing data that could be given succinctly in text. A copy of each table must be submitted with the manuscript in an editable format and must be accessible for copyediting. Tables cannot be embedded within the document or provided as figure art. In terms of data presentation, values expressed in the same unit of measurement should read down, not across; when percentages are presented, the appropriate numbers must also be given. In preparing the tables, each cell should contain only one item of data. In rows, subcategories should be in separate cells; in columns, Ns and %s or Means and SDs should be in separate cells. For optimum readability and presentation, tables should not exceed 120 characters in width.

Figures:


Figures express trends or relationships between data. Consult recent issues of the Journal and the following guidelines for format. Figures that contain numerical data that could be expressed more succinctly or clearly in tabular form should be converted to tables. Submission of previously published figures is discouraged. Multiple figures for the same article should be prepared as a set, consistent in colour and size across all figures.

Figure Submission-

  1. A copy of each figure must accompany the manuscript.
  2. Figure titles and footnotes should be provided within the text of the manuscript.
  3. If figures have been previously adapted from an earlier publication, the author must secure written permission from the holder of copyright for use in the Journal. The author should submit a copy of the permission release and credit lines if the manuscript is accepted for publication.
     

Figure Format-

  1. Specific file formats are required for different types of figure images. For photos or scans, high resolution (300 dpi) raster images in .jpg, .png, or .tiff formats are preferred. For charts and graphs, scalable and editable vector images in .eps, .pdf, or .svg formats should be provided. We can also accept native files for charts and graphs created in Word, PowerPoint, or Adobe Illustrator.
  2. Two-dimensional graphs should not be represented in three dimensions.

Figure Content-

  1. Each complete figure (including titles and footnotes) should be understandable without reference to the text.
  2. Figures should represent data visually rather than numerically.
  3. If error bars are included, standard deviations, rather than standard errors of the mean, should be used.
  4. Only the most widely recognized abbreviations may be used.
  5. Ordinary footnotes should be cited with lower-case superscript letters. Footnote citations may be given in both the title and the body of the figure; within the body of the figure, they should proceed from left to right.
  6. For statistical comparisons noted in figures, provide complete statistical data in footnotes. If numerous analyses are presented, simple p values may be given in the footnotes, in which case the footnotes should be indicated by single asterisk, double asterisk, etc.

Supplemental Data:

The Journal doesn’t allow authors to submit supplemental data to be posted online in support of their printed articles. To be accepted for posting, supplemental material must be essential to the scientific integrity and excellence of the manuscript. The material is subject to the same editorial standards as the printed Journal and will be submitted for peer review. Supplemental material will not be formatted or edited by in-house editorial staff to the extent as performed for material appearing in the print version. The Editor may select material submitted for publication in the print version to be posted online only. The Journal will accept the following categories of supplemental data:

  • Detailed tables (up to 3) that contain data of use to other investigators. Data should be summarized in the text of the print version
  • The CONSORT table and figure for clinical trials are also appropriate for online publication only.
  • Questionnaires, tests, checklists, etc., should be submitted as supplemental data.

If your document type is not listed here, please contact the editorial office at 9vom365@gmail.com. Please name your files and cite within the printed text as ST1 for tables, SF1 for figures, SR1 for references, and SA1 for appendices.

 

Conflict of interest

All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations that could inappropriately influence, or be perceived to influence, their work.

 

Role of the funding source

You are requested to identify provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

 

Processing Charges

There are no processing charges for publication of an article in the journal (HTNJ).